Two Groups Of Scientists Transplanted Human Poop To Study Cancer. The Results Were Extraordinary

Add Sciencing on Google:

It might be gross to imagine, but scientists and doctors have been experimenting with the medical applications of human poop for a long time. Archaeologists found that ancient Roman doctors would prescribe treatments containing poop for carcinoma. Although the effectiveness of the ancient treatment is unknown, two studies reveal how modern-day scientists have transplanted human poop into cancer patients as a way to treat melanoma, a dangerous form of skin cancer — with surprising success.

The goal of both studies was to improve the effectiveness of a form of cancer treatment called immunotherapy. Unlike chemotherapy, which uses powerful drugs to kill cancer cells, immunotherapy trains the body's own immune system to attack the cancer. Immunotherapies can work in different ways and can come from different sources, even ancient proteins. Some cancer patients show huge improvements on immunotherapy, but many others are resistant to the treatment. Immunotherapy for melanoma, for example, is effective in only 40% of patients.

Researchers have found that the gut microbiome, the makeup of bacteria in a person's intestinal tract, has a strong effect on whether cancer patients respond to immunotherapy or not. In the studies, the scientists took poop from patients who did respond to the immunotherapy and transplanted it into patients who didn't. Then, they tested whether the new microbiome would allow those patients to become receptive to the immunotherapy treatment and help shrink their melanoma.

A poop transplant opens new treatment opportunities

The first study, published in Science, was a clinical trial to assess whether a poop transplant followed by immunotherapy for melanoma would be safe and feasible. The researchers treated 10 patients with antibiotics to kill their own microbiome and then administered a solution of poop from two donors into their gut either through both a colonoscopy and oral pills. The two poop donors had been successfully treated for melanoma using immunotherapy.

After the poop transplant, the patients received the immunotherapy drug and additional poop transplants every two weeks for three months. All patients tolerated the treatment well, and three of the 10 patients saw their tumors shrink after the poop transplant. The tumor in one of the patients completely disappeared.

The second study, also published in Science, took a similar approach but treated 15 patients using the poop from seven donors. None of the patients had any response to immunotherapy before. After the poop transplant, however, six of the 15 showed a reduction in the size of their tumors or their disease was stable for more than a year.

A shifting microbiome

The studies took a closer look at the bacteria in the poop donors and recipients, before and after the transplant, to see how they impacted whether the treatment worked. In the first study, one of the two donors had more gut bacteria that are associated with good responses to immunotherapy, and the patients who received poop from that donor were the ones who responded to the treatment. In the second study, the researchers saw that when the patients' microbiomes following the transplant more closely resembled the donors' microbiomes, the patients responded better to the treatment. Both studies pointed to the same broad families of bacteria that were present in patients who responded to the immunotherapy.

The scientists still have many unanswered questions. Future studies will need to scale up the number of patients treated with poop transplants to solidify how effective the poop transplant approach is. The precise mixture of gut bacteria species that help patients respond to immunotherapy, and what exactly those bacteria are doing in the gut, are also major sources of future work. But despite the research still to be done, the studies offer hope that, in the future, poop transplants could propel better cancer treatments.

Recommended